2024年5月20日 · Multidrug-resistant TB (MDR-TB) is a form of TB disease caused by a strain of M. tuberculosis complex that is resistant to rifampicin and isoniazid. Globally, an estimated …

Multidrug-resistant tuberculosis (MDR-TB) is a form of tuberculosis (TB) infection caused by bacteria that are resistant to treatment with at least two of the most powerful first-line anti-TB …

耐多药结核病（MDR-TB）是一种 由对利福平和异烟肼具有耐药性的结核分枝杆菌复合群菌株引起的结核病。 2022年，全球估计有41万人（95%置信区间：37万 - 45万）患有耐多药结核病或 …

2023年12月21日 · Multidrug-resistant TB disease (MDR TB) is caused by germs that are resistant to two or more of the main TB medicines: isoniazid and rifampin. Two more serious forms of …

2025年1月6日 · Multidrug-resistant TB (MDR TB) disease is caused by TB bacteria that are resistant to at least isoniazid and rifampin, the most effective first-line TB treatment drugs. …

2024年3月24日 · Multidrug-resistant or rifampicin-resistant TB (MDR/RR-TB; resistance to rifampicin and isoniazid, or rifampicin alone) is a burgeoning public health challenge in several …

WHO发表了首次全球范围内多重耐药结核菌（MDR-TB）感染的总体评估，调查显示，2004年全球MDR-TB感染患者估计共424203例，9个独立变量可能与结核菌多重耐药相关。[J Infect Dis …

Most attention has been given to the proportion of people diagnosed with TB who have rifampicin-resistant TB (RR-TB) and multidrug-resistant TB (MDR-TB, defined as resistance to both …

For MDR-TB, rapid molecular diagnostic tests such as the Xpert MTB/RIF, a cartridge-based automated molecular assay which was endorsed by WHO in 2016 as an initial test for TB and …

「多重抗藥性結核病」（MultiDrug-Resistant Tuberculosis）是指檢體經衛生福利部疾病管制署實驗室藥物敏感性試驗後發現，感染至少同時對Isoniazid（INH）及Rifampin（RMP）二種第一 …